EFFECT OF A DELAY IN STARTING CHEMOTHERAPY FOR PATIENTS (PTS) WITH DIFFUSE LARGE-CELL NON-HODGKINS-LYMPHOMA (NHL)

被引：0
|
作者：
BIERMAN, P [1 ]
ANDERSON, J [1 ]
VOSE, J [1 ]
SLOWIACZEK, K [1 ]
MORRIS, M [1 ]
ARMITAGE, J [1 ]
机构：
[1] UNIV NEBRASKA,MED CTR,OMAHA,NE 68105
来源：
BLOOD | 1994年 / 84卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A165 / A165
页数：1
相关论文
共 50 条
  • [21] PREDICTIVE VALUE OF THE INTERNATIONAL PROGNOSTIC INDEX IN NON-HODGKINS-LYMPHOMA SUBTYPES OTHER THAN LARGE-CELL LYMPHOMAS
    ROGGERO, E
    ZUCCA, E
    PINOTTI, G
    BERNASCONI, A
    DEVECCHIS, L
    CAVALLI, F
    BLOOD, 1994, 84 (10) : A157 - A157
  • [22] TREATMENT OF ADVANCED LARGE-CELL NON-HODGKINS-LYMPHOMA IN CHILDHOOD - A PEDIATRIC-ONCOLOGY-GROUP (POG) STUDY
    PICK, T
    WEINSTEIN, H
    SCHWENN, M
    HVIZDALDA, E
    TARBELL, N
    SHUSTER, J
    HUTCHISON, R
    BERARD, C
    MURPHY, SB
    BLOOD, 1993, 82 (10) : A333 - A333
  • [23] PRIMARY ANAPLASTIC LARGE-CELL NON-HODGKINS-LYMPHOMA (ALCL) IN ADULTS - A CLINICOPATHOLOGICAL STUDY OF 122 CASES COMPARED TO A COHORT OF 1173 NONANAPLASTIC LARGE-CELL LYMPHOMA - A GELA STUDY
    DAGAY, MF
    BRIERE, J
    LEPAGE, E
    SYMANN, M
    DUVAL, C
    REYES, F
    BERGER, F
    COIFFIER, B
    GAULARD, P
    DELSOL, G
    DIEBOLD, J
    GISSELBRECHT, C
    BLOOD, 1993, 82 (10) : A135 - A135
  • [24] EFFECTS OF THYMOSTIMULIN WITH COMBINATION CHEMOTHERAPY IN PATIENTS WITH AGGRESSIVE NON-HODGKINS-LYMPHOMA
    FEDERICO, M
    GOBBI, PG
    MORETTI, G
    AVANZINI, P
    DIRENZO, N
    CAVANNA, L
    ASCARI, E
    SILINGARDI, V
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1995, 18 (01): : 8 - 14
  • [25] CARMUSTINE, ETOPOSIDE, CYTARABINE AND CYCLOPHOSPHAMIDE (BVAC) WITH AUTOLOGOUS STEM-CELL TRANSPLANT (SCT) FOR PATIENTS WITH CHEMOTHERAPY-SENSITIVE RELAPSED HODGKINS LYMPHOMA (HL) AND NON-HODGKINS-LYMPHOMA (NHL)
    PECORA, AL
    BROCHSTEIN, JA
    VANVLIET, A
    ZAHOS, K
    BLOOD, 1993, 82 (10) : A574 - A574
  • [26] Impact of Poly-chemotherapy on the Nutritional Status of Patients With Diffuse Large-cell Lymphoma
    Ramdane, Houria
    Ouznadji, Amira
    Bestani, Amira
    Bouras, Fatma-Zohra
    Koceir, El-hadj Ahmed
    ACTA PHYSIOLOGICA, 2018, 224
  • [27] INTERFERON ALFA COMBINED WITH CYTOTOXIC CHEMOTHERAPY FOR PATIENTS WITH NON-HODGKINS-LYMPHOMA
    SMALLEY, RV
    ANDERSEN, JW
    HAWKINS, MJ
    BHIDE, V
    OCONNELL, MJ
    OKEN, MM
    BORDEN, EC
    NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (19): : 1336 - 1341
  • [28] FULL DOSE CHOP CHEMOTHERAPY IN ELDERLY PATIENTS WITH NON-HODGKINS-LYMPHOMA
    EPELBAUM, R
    HAIM, N
    LEVIOV, M
    BENSHAHAR, M
    BENARIE, Y
    DROR, Y
    FARAGGI, D
    ACTA ONCOLOGICA, 1995, 34 (01) : 87 - 91
  • [29] AUTOLOGOUS PROGENITOR-CELL TRANSPLANTATION (APCT) FOR NON-HODGKINS-LYMPHOMA (NHL) AND HODGKINS-DISEASE (HD)
    SCIGLIANO, E
    ISOLA, L
    ZANGARI, M
    ROSS, V
    ENGLISH, A
    SKERRETT, D
    MANDELL, L
    LAVIGNINI, P
    SHANK, B
    VLACHOS, A
    LIPTON, J
    FRUCHTMAN, S
    BLOOD, 1994, 84 (10) : A721 - A721
  • [30] MACOP-B CHEMOTHERAPY FOR THE TREATMENT OF DIFFUSE LARGE-CELL LYMPHOMA
    KLIMO, P
    CONNORS, JM
    ANNALS OF INTERNAL MEDICINE, 1985, 102 (05) : 596 - 602
12345